VIVS

Conviction 0HealthcareScan · Thu, Jun 25, 2026

VIVS$1.10+0.92%

ResistanceSupportVol 14

Vol MA14 76.73K

Mar 26Apr 14May 1May 19Jun 8Jun 25

VivoSim Labs, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.organovo.com ↗

Price1.10

Change+0.92%

Gap+2.75%

Rel volume0.47×

Avg volume70.27K

Avg $ vol83.48K

SMA 201.20

SMA 501.32

SMA 2002.05

Price vs 50-16.72%

Price vs 200-46.33%

MA stackbearish

50/200 cross—

Supertrenddown · 1.35

RSI (14)35

MACD hist-0.00

MACD cross—

Stoch %K / %D7 / 8

ADX (14)12

+DI / −DI13 / 18

RSI divergence—

MACD divergence—

ATR %+7.28%

ADR %6.16%

52w high4.78

52w low1.09

From 52w high-76.99%

Above 52w low+0.92%

New 52w highNo

SqueezeOff

Bollinger width25.70%

%B0.19

Donchian pos7.41%

Donchian high1.35

Donchian low1.08

AVWAP (52w high)2.67

vs AVWAP high-58.84%

AVWAP (52w low)1.11

vs AVWAP low-0.71%

OBV trendDown

Chaikin MF (20)-0.36

Today vs 20d0.47×

Avg vol (14d)76.73K

Avg vol (20d)70.27K

Avg $ vol (20d)83.48K

Market cap2.87M

RS 3m (vs SPY)-44.97%

RS 6m (vs SPY)-52.69%

RS line new highNo

Trend template0/8

Technical rank9.7

1 week-2.65%

1 month-14.73%

3 months-35.29%

6 months-44.44%

1 year-28.34%

YTD-41.49%

P/E-1.15

P/B0.65

P/S19.92

P/FCF-0.30

EPS-1.70

Div yield—

ROE-56.02%

ROA-35.75%

Debt/Eq—

Current2.44

EV/EBITDA0.11

Gross margin—

Net margin—

Rev growth32.11%

EPS growth83.04%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-1.42M

Revenue26K

Net income-2.69M

Gross profit—

Free cash flow-9.47M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out—

Employees9

ListedTue, Aug 16, 2011

Free float2.54M

Float %97.5%

Short interest33.34K

Days to cover0.7d

Short volume25.9%

Squeeze score6 / 100

Next earningsThu, Jun 25, 2026 (0d)

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank9.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.51

Support1.12

Days since event—

Candle confirm—

News sentiment—

Financials as of Wed, Dec 31, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in VIVS

All disclosures →

No recent disclosed trades by Congress in VIVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VIVS

No recent insider (Form 4) filings in VIVS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VIVS

EDGAR →

No recent SEC filings on file for VIVS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.